Dunno how much the US FDA is to blame here: these API plants pretty much supply the world with generics.

If anything, it's the FDA that's doing foreign plant inspections and every other country's regulator just does what the FDA does.

My real question is: Why is each country doing its own inspections? Why not one global inspection?

Everyone else is getting a free ride from the FDA's work.